Phyllis Ferrell is an innovator, investor, and incubator for longevity. She is passionate about brain health and committed to creating a world that allows our global aging population and economies to thrive. After three decades as a life sciences executive at Eli Lilly & Company, Phyllis retired from the pharmaceutical business and is now working with for-profit and non-profit investors to transform health systems around the world. She loves tackling tough problems with great people and leads cross-functional teams with care and candor.
In 2020, Phyllis was placed as an executive-on-loan to the World Economic Forum-commissioned Davos Alzheimer’s Collaborative (DAC), where she has served as the visionary and leader of the Healthcare System Preparedness program. DAC is a global multi-stakeholder partnership of organizations aimed at mobilizing the world against Alzheimer’s disease, with the specific focus of ensuring that health systems are prepared to embrace innovation and better care for our global aging population.
Phyllis has a BA in Economics from DePauw University and an MBA from Stanford University. Phyllis is a current member of the World Dementia Council, an advisory committee member of the Milken Institute Center for Future of Aging, and the USC Clinical Trial Recruiting Laboratory and will remain an advisor for the Davos Alzheimer’s Collaborative. Phyllis is passionate about Alzheimer’s advocacy and brain health so that other boys don’t have to grow up without their grandfathers’ presence as her sons did.